These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13250119)

  • 1. Haeminisoniazid interaction and the effect of haemin in reviving isoniazid-treated tubercle bacilli.
    KNOX R; WOODROFFE RC
    Br J Exp Pathol; 1955 Aug; 36(4):425-31. PubMed ID: 13250119
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemotherapeutic agents and their resistance against tubercle bacilli. III. Hemin starch liquid medium for the cultivation of isoniazid-susceptible and resistant tubercle bacilli.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Oct; 6(3):377-90. PubMed ID: 13298725
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of isoniazid on growing and resting tubercle bacilli.
    SCHAEFER WB
    Am Rev Tuberc; 1954 Jan; 69(1):125-7. PubMed ID: 13114634
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the virulence of chemoresistant tubercle bacilli. II. Tubercle bacilli which have become resistant to isoniazid in vivo].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 110(6):538-46. PubMed ID: 13159801
    [No Abstract]   [Full Text] [Related]  

  • 5. Virulence of tubercle bacilli recovered from patients treated with isoniazid.
    STEENKEN W; WOLINSKY E
    Am Rev Tuberc; 1953 Oct; 68(4):548-56. PubMed ID: 13104867
    [No Abstract]   [Full Text] [Related]  

  • 6. Virulence of isoniazid-resistant tubercle bacilli.
    MITCHISON DA
    Am Rev Tuberc; 1954 Apr; 69(4):640-1. PubMed ID: 13148527
    [No Abstract]   [Full Text] [Related]  

  • 7. Public health significance of tubercle bacilli resistant to isoniazid.
    WIDELOCK D; PEIZER LR; KLEIN S
    Am J Public Health Nations Health; 1955 Jan; 45(1):79-83. PubMed ID: 13218190
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro.
    COHN ML; ODA U; KOVITZ C; MIDDLEBROOK G
    Am Rev Tuberc; 1954 Sep; 70(3):465-75. PubMed ID: 13189061
    [No Abstract]   [Full Text] [Related]  

  • 9. Regression of tuberculous lesions in guinea pigs infected with isoniazid-resistant tubercle bacilli.
    KARLSON AG
    Am Rev Tuberc; 1954 Sep; 70(3):531-2. PubMed ID: 13189071
    [No Abstract]   [Full Text] [Related]  

  • 10. Revival of tubercle bacilli after prolonged in vitro exposure to isoniazid.
    FISHER MW
    Proc Soc Exp Biol Med; 1954 Apr; 85(4):538-40. PubMed ID: 13167130
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the development of resistance of tubercle bacilli to isoniazid.
    VENNESLAND K
    Trans Annu Meet Natl Tuberc Assoc; 1953; 49():183-91. PubMed ID: 13136314
    [No Abstract]   [Full Text] [Related]  

  • 12. The chemotherapeutic agents and the resistance against tubercle bacilli. I. The inactivation and the tuberculocidal effect of isoniazid.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Jan; 6(1):97-106. PubMed ID: 13246660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isonicotinic acid hydrazide-resistant tubercle bacilli in the course of therapy of pulmonary tuberculosis].
    ZEBROWSKI T; PIENIAZEK J; PLEWIK W
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 109(3):300-2. PubMed ID: 13093599
    [No Abstract]   [Full Text] [Related]  

  • 14. Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in guinea-pigs.
    MITCHISON DA
    Br Med J; 1954 Jan; 1(4854):128-30. PubMed ID: 13106496
    [No Abstract]   [Full Text] [Related]  

  • 15. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
    MIDDLEBROOK G
    Am Rev Tuberc; 1954 Mar; 69(3):471-2. PubMed ID: 13138881
    [No Abstract]   [Full Text] [Related]  

  • 16. Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea-pigs and mice.
    BARNETT M; BUSBY SR; MITCHISON DA
    Br J Exp Pathol; 1953 Oct; 34(5):568-81. PubMed ID: 13106225
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of isoniazid and streptomycin on acid-fastness, tetrazolium reduction, growth, and survival of tubercle bacilli.
    KOCH-WESER D; BARCLAY WR; EBERT RH
    Am Rev Tuberc; 1955 Apr; 71(4):556-65. PubMed ID: 14361969
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants.
    COHN ML; KOVITZ C; ODA U; MIDDLEBROOK G
    Am Rev Tuberc; 1954 Oct; 70(4):641-64. PubMed ID: 13197742
    [No Abstract]   [Full Text] [Related]  

  • 19. [Congruence of resistance of tubercle bacilli to rimifon in the test tube and in animal experiment].
    FUST B; STUDER A; BOHNI E
    Schweiz Z Tuberk; 1953; 10(4):328-33. PubMed ID: 13135500
    [No Abstract]   [Full Text] [Related]  

  • 20. The bactericidal action of isoniazid, streptomycin and terramycin on extracellular and intracellular tubercle bacilli.
    MACKANESS GB; SMITH N
    Am Rev Tuberc; 1953 Mar; 67(3):322-40. PubMed ID: 13031052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.